Company K2X Technology & Life Science, Inc.

Equities

KBPH

US5015722003

Financial & Commodity Market Operators

Market Closed - OTC Markets 20:30:56 22/08/2022 BST 5-day change 1st Jan Change
1 USD -45.65% Intraday chart for K2X Technology & Life Science, Inc. -.--% -.--%

Business Summary

Kyto Technology and Life Science, Inc. is an investment company focused on creating an exchange-traded fund (ETF)-like vehicle of diversified and thoroughly vetted start-ups thus defining an entirely new non-correlated asset class. The Company’s portfolio includes AbFero Pharmaceuticals Inc., Achelios Therapeutics, Inc., Altis Biosystems, AmplifiDX, AOA Inc., Astrocyte Pharmaceuticals Inc. and other.

Number of employees: 1

Managers

Managers TitleAgeSince
Chief Executive Officer 81 04/03/99
Director of Finance/CFO 75 14/03/18
Investor Relations Contact - 31/12/18
Corporate Officer/Principal 76 -
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 81 04/03/99
Director/Board Member 72 07/01/21
Director/Board Member 88 07/01/21
Director/Board Member - 07/01/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 13,287,621 7,124,701 ( 53.62 %) 0 53.62 %
Stock B 0 4,200,000 0 0

Shareholders

NameEquities%Valuation
12,500 2.273 % 28 125 $

Company contact information

Kyto Technology & Life Science, Inc.

13050 La Paloma Road

94022, Los Altos Hills

+

http://www.kytotech.com
address K2X Technology & Life Science, Inc.(KBPH)
  1. Stock Market
  2. Equities
  3. KBPH Stock
  4. Company K2X Technology & Life Science, Inc.